Additionally, the 36-month beta value for TDOC is 0.95. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 4 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for TDOC is 165.20M and currently, short sellers hold a 12.28% ratio of that float. The average trading volume of TDOC on April 08, 2024 was 4.68M shares.
TDOC) stock’s latest price update
The stock price of Teladoc Health Inc (NYSE: TDOC) has jumped by 1.68 compared to previous close of 14.25. Despite this, the company has seen a fall of -4.04% in its stock price over the last five trading days. The Motley Fool reported 2024-04-07 that Teladoc Health’s board of directors announced the departure of its CEO. Shares of Teladoc have lost nearly half their value since the company’s initial public offering in 2015.
TDOC’s Market Performance
Teladoc Health Inc (TDOC) has seen a -4.04% fall in stock performance for the week, with a -0.62% decline in the past month and a -32.16% plunge in the past quarter. The volatility ratio for the week is 4.40%, and the volatility levels for the past 30 days are at 3.41% for TDOC. The simple moving average for the past 20 days is -3.72% for TDOC’s stock, with a -27.89% simple moving average for the past 200 days.
Analysts’ Opinion of TDOC
Many brokerage firms have already submitted their reports for TDOC stocks, with Cantor Fitzgerald repeating the rating for TDOC by listing it as a “Overweight.” The predicted price for TDOC in the upcoming period, according to Cantor Fitzgerald is $22 based on the research report published on February 29, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $17. The rating they have provided for TDOC stocks is “Market Perform” according to the report published on February 26th, 2024.
DA Davidson gave a rating of “Neutral” to TDOC, setting the target price at $22 in the report published on January 17th of the current year.
TDOC Trading at -14.78% from the 50-Day Moving Average
After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -52.35% of loss for the given period.
Volatility was left at 3.41%, however, over the last 30 days, the volatility rate increased by 4.40%, as shares sank -5.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.23% lower at present.
During the last 5 trading sessions, TDOC fell by -4.04%, which changed the moving average for the period of 200-days by -41.76% in comparison to the 20-day moving average, which settled at $15.01. In addition, Teladoc Health Inc saw -32.76% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TDOC starting from Nanis Nikolaos P., who sale 461 shares at the price of $14.31 back on Apr 02 ’24. After this action, Nanis Nikolaos P. now owns 70,621 shares of Teladoc Health Inc, valued at $6,599 using the latest closing price.
Geshuri Arnnon, the CHIEF PEOPLE OFFICER of Teladoc Health Inc, sale 7,500 shares at $15.06 during a trade that took place back on Mar 25 ’24, which means that Geshuri Arnnon is holding 38,470 shares at $112,950 based on the most recent closing price.
Stock Fundamentals for TDOC
Current profitability levels for the company are sitting at:
- -0.1 for the present operating margin
- 0.71 for the gross margin
The net margin for Teladoc Health Inc stands at -0.08. The total capital return value is set at -0.06. Equity return is now at value -9.51, with -4.69 for asset returns.
Based on Teladoc Health Inc (TDOC), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 0.68. The interest coverage ratio of the stock is -11.15.
Currently, EBITDA for the company is 192.05 million with net debt to EBITDA at -2.9. When we switch over and look at the enterprise to sales, we see a ratio of 1.11. The receivables turnover for the company is 11.31for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.46.
Conclusion
In conclusion, Teladoc Health Inc (TDOC) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
